Skip Navigation


International Immunology Advance Access originally published online on June 28, 2004
International Immunology 2004 16(8):1143-1154; doi:10.1093/intimm/dxh115
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/8/1143    most recent
dxh115v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Funami, K.
Right arrow Articles by Seya, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Funami, K.
Right arrow Articles by Seya, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© 2004 The Japanese Society for Immunology


ORIGINAL RESEARCH PAPERS

The cytoplasmic ‘linker region’ in Toll-like receptor 3 controls receptor localization and signaling

Kenji Funami1,2,4, Misako Matsumoto1,2, Hiroyuki Oshiumi1, Takashi Akazawa1, Akitsugu Yamamoto3 and Tsukasa Seya1,2,4

1 Department of Immunology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Higashinari-ku, Osaka 537-8511, Japan
2 Department of Molecular Immunology, Nara Institute of Science and Technology, Ikoma, Nara 630-0101, Japan
3 Department of Cell Biology, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga 526-0829, Japan
4 Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan

Correspondence to: M. Matsumoto; E-mail: matumoto-mi{at}mc.pref.osaka.jp

Toll-like receptor 3 (TLR3) recognizes double-stranded RNA and transmits signals to activate NF-{kappa}B and the interferon (IFN)-ß promoter via the newly identified adaptor, TICAM-1. The extracellular LRR domain of TLR3 is engaged in the ligand recognition, while the intracellular TIR domain is crucial for the adaptor binding and signal transduction upon ligand stimulation. Here, we analyzed TLR3 localization in human monocyte-derived immature dendritic cells (iDCs) and stable transfectants expressing human TLR3 by immunofluorescence staining and confocal microscopy. TLR3 was predominantly localized in specific but as yet unidentified intracellular vesicles where TLR3 signaling was initiated. Expression analysis of TLR3-tail-truncated mutants revealed that the cytoplasmic ‘linker’ region (residues 730–755) determines the intracellular localization of TLR3. Site-directed mutagenesis of the linker region allowed us to identify the relevant determinants as Arg740 and Val741 residues for intracellular expression of TLR3. Furthermore, alanine scanning of the linker region demonstrated that the Phe732, Leu742 and Gly743 in the TLR3 cytoplasmic linker region are essential for ligand-induced NF-{kappa}B and IFN-ß promoter activation. Thus, the cytoplasmic linker region of TLR3 regulates receptor retention inside the organelle and signaling, which may be closely linked to TLR3 function in DCs.

Keywords: dendritic cell, innate immunity, TLR adaptors, type I interferon, viral infection

Transmitting editor: T. Takai


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
K. Itoh, A. Watanabe, K. Funami, T. Seya, and M. Matsumoto
The Clathrin-Mediated Endocytic Pathway Participates in dsRNA-Induced IFN-{beta} Production
J. Immunol., October 15, 2008; 181(8): 5522 - 5529.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. R. Wilson, P. F. de Sessions, M. A. Leon, and F. Scholle
West Nile Virus Nonstructural Protein 1 Inhibits TLR3 Signal Transduction
J. Virol., September 1, 2008; 82(17): 8262 - 8271.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Matsuo, H. Oshiumi, T. Tsujita, H. Mitani, H. Kasai, M. Yoshimizu, M. Matsumoto, and T. Seya
Teleost TLR22 Recognizes RNA Duplex to Induce IFN and Protect Cells from Birnaviruses
J. Immunol., September 1, 2008; 181(5): 3474 - 3485.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
E. Vercammen, J. Staal, and R. Beyaert
Sensing of Viral Infection and Activation of Innate Immunity by Toll-Like Receptor 3
Clin. Microbiol. Rev., January 1, 2008; 21(1): 13 - 25.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. Sivori, M. Falco, S. Carlomagno, E. Romeo, L. Moretta, and A. Moretta
Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors
Int. Immunol., December 1, 2007; 19(12): 1341 - 1348.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Funami, M. Sasai, Y. Ohba, H. Oshiumi, T. Seya, and M. Matsumoto
Spatiotemporal Mobilization of Toll/IL-1 Receptor Domain-Containing Adaptor Molecule-1 in Response to dsRNA
J. Immunol., November 15, 2007; 179(10): 6867 - 6872.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. D. Gilfoy and P. W. Mason
West Nile Virus-Induced Interferon Production Is Mediated by the Double-Stranded RNA-Dependent Protein Kinase PKR
J. Virol., October 15, 2007; 81(20): 11148 - 11158.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. T. Ranjith-Kumar, W. Miller, J. Sun, J. Xiong, J. Santos, I. Yarbrough, R. J. Lamb, J. Mills, K. E. Duffy, S. Hoose, et al.
Effects of Single Nucleotide Polymorphisms on Toll-like Receptor 3 Activity and Expression in Cultured Cells
J. Biol. Chem., June 15, 2007; 282(24): 17696 - 17705.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
M. M. Brinkmann, E. Spooner, K. Hoebe, B. Beutler, H. L. Ploegh, and Y.-M. Kim
The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling
J. Cell Biol., April 23, 2007; 177(2): 265 - 275.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. T. Ranjith-Kumar, W. Miller, J. Xiong, W. K. Russell, R. Lamb, J. Santos, K. E. Duffy, L. Cleveland, M. Park, K. Bhardwaj, et al.
Biochemical and Functional Analyses of the Human Toll-like Receptor 3 Ectodomain
J. Biol. Chem., March 9, 2007; 282(10): 7668 - 7678.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
W. A. Derbigny, S.-C. Hong, M. S. Kerr, M. Temkit, and R. M. Johnson
Chlamydia muridarum Infection Elicits a Beta Interferon Response in Murine Oviduct Epithelial Cells Dependent on Interferon Regulatory Factor 3 and TRIF
Infect. Immun., March 1, 2007; 75(3): 1280 - 1290.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Sasai, M. Shingai, K. Funami, M. Yoneyama, T. Fujita, M. Matsumoto, and T. Seya
NAK-Associated Protein 1 Participates in Both the TLR3 and the Cytoplasmic Pathways in Type I IFN Induction
J. Immunol., December 15, 2006; 177(12): 8676 - 8683.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. A. Steer, J. M. Moran, B. S. Christmann, L. B. Maggi Jr, and J. A. Corbett
Role of MAPK in the Regulation of Double-Stranded RNA- and Encephalomyocarditis Virus-Induced Cyclooxygenase-2 Expression by Macrophages.
J. Immunol., September 1, 2006; 177(5): 3413 - 3420.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. M. Miggin and L. A. J. O'Neill
New insights into the regulation of TLR signaling
J. Leukoc. Biol., August 1, 2006; 80(2): 220 - 226.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. J. Groskreutz, M. M. Monick, L. S. Powers, T. O. Yarovinsky, D. C. Look, and G. W. Hunninghake
Respiratory Syncytial Virus Induces TLR3 Protein and Protein Kinase R, Leading to Increased Double-Stranded RNA Responsiveness in Airway Epithelial Cells
J. Immunol., February 1, 2006; 176(3): 1733 - 1740.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
T. Seya, K. Funami, M. Taniguchi, and M. Matsumoto
Antibodies against human Toll-like receptors (TLRs): TLR distribution and localization in human dendritic cells
Innate Immunity, December 1, 2005; 11(6): 369 - 374.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
O. de Bouteiller, E. Merck, U. A. Hasan, S. Hubac, B. Benguigui, G. Trinchieri, E. E. M. Bates, and C. Caux
Recognition of Double-stranded RNA by Human Toll-like Receptor 3 and Downstream Receptor Signaling Requires Multimerization and an Acidic pH
J. Biol. Chem., November 18, 2005; 280(46): 38133 - 38145.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Nishiya, E. Kajita, S. Miwa, and A. L. DeFranco
TLR3 and TLR7 Are Targeted to the Same Intracellular Compartments by Distinct Regulatory Elements
J. Biol. Chem., November 4, 2005; 280(44): 37107 - 37117.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. Honda, H. Yanai, A. Takaoka, and T. Taniguchi
Regulation of the type I IFN induction: a current view
Int. Immunol., November 1, 2005; 17(11): 1367 - 1378.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. Fensterl, D. Grotheer, I. Berk, S. Schlemminger, A. Vallbracht, and A. Dotzauer
Hepatitis A Virus Suppresses RIG-I-Mediated IRF-3 Activation To Block Induction of Beta Interferon
J. Virol., September 1, 2005; 79(17): 10968 - 10977.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
K. Pal, C. S. Kaetzel, K. Brundage, C. A. Cunningham, and C. F. Cuff
Regulation of polymeric immunoglobulin receptor expression by reovirus
J. Gen. Virol., August 1, 2005; 86(8): 2347 - 2357.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Nakao, K. Funami, S. Kikkawa, M. Taniguchi, M. Nishiguchi, Y. Fukumori, T. Seya, and M. Matsumoto
Surface-Expressed TLR6 Participates in the Recognition of Diacylated Lipopeptide and Peptidoglycan in Human Cells
J. Immunol., February 1, 2005; 174(3): 1566 - 1573.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. Takeda and S. Akira
Toll-like receptors in innate immunity
Int. Immunol., January 1, 2005; 17(1): 1 - 14.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.